Patents by Inventor Shantanu Sule

Shantanu Sule has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITIONS CONTAINING ANTI-BETA AMYLOID ANTIBODIES
    Publication number: 20240043513
    Abstract: Pharmaceutical compositions containing anti-beta amyloid (A?) antibodies or A?-binding fragments thereof are provided. These pharmaceutical compositions find use in the treatment of abnormal accumulation or deposition of A? in the central nervous system, mild cognitive impairment, and A?-associated disorders such as Alzheimer's disease.
    Type: Application
    Filed: April 13, 2023
    Publication date: February 8, 2024
    Inventors: Steven Andrew Lantz, Kapil Gupta, Shantanu Sule, Adnan Zunic
  • Pharmaceutical compositions containing anti-beta amyloid antibodies
    Patent number: 11655289
    Abstract: Pharmaceutical compositions containing anti-beta amyloid (A?) antibodies or AD-binding fragments thereof are provided. These pharmaceutical compositions find use in the treatment of abnormal accumulation or deposition of A? in the central nervous system, mild cognitive impairment, and AD-associated disorders such as Alzheimer's disease.
    Type: Grant
    Filed: August 22, 2018
    Date of Patent: May 23, 2023
    Assignee: Biogen MA Inc.
    Inventors: Steven Andrew Lantz, Kapil Gupta, Shantanu Sule, Adnan Zunic
  • PHARMACEUTICAL COMPOSITIONS CONTAINING ANTI-BETA AMYLOID ANTIBODIES
    Publication number: 20210188954
    Abstract: Pharmaceutical compositions containing anti-beta amyloid (A?) antibodies or AD-binding fragments thereof are provided. These pharmaceutical compositions find use in the treatment of abnormal accumulation or deposition of A? in the central nervous system, mild cognitive impairment, and AD-associated disorders such as Alzheimer's disease.
    Type: Application
    Filed: August 22, 2018
    Publication date: June 24, 2021
    Inventors: Steven Andrew Lantz, Kapil Gupta, Shantanu Sule, Adnan Zunic
  • PHARMACEUTICAL COMPOSITIONS AND DOSAGE REGIMENS FOR CLINICAL USE OF ANTI-BLOOD DENDRITIC CELL ANTIGEN 2 ANTIBODIES
    Publication number: 20190284281
    Abstract: Formulations and dosage regimens of anti-Blood Dendritic Cell Antigen 2 (BDCA2) antibodies are provided. These formulations and dosage regimens find use in the treatment of BDCA2-associated disorders such as systematic lupus erythematosus, cutaneous lupus eiythernatosus, and discoid lupus erythematosus, and cytokine release syndrome.
    Type: Application
    Filed: April 27, 2017
    Publication date: September 19, 2019
    Applicant: Biogen MA Inc.
    Inventors: Mark R.H. Krebs, David Dai, Shantanu Sule, Dania Rabah, David Martin
  • FORMULATIONS AND SCREENING OF BIOLOGICAL THERAPEUTIC AGENTS
    Publication number: 20190064147
    Abstract: Provided herein, in some aspects, are methods of developing a biological therapeutic product. The methods can be used to formulate a biological therapeutic agent or screen biological therapeutic agents.
    Type: Application
    Filed: January 18, 2016
    Publication date: February 28, 2019
    Applicant: Biogen MA Inc.
    Inventors: Mark Krebs, Mariana Dimitrova, Kapil Gupta, Shantanu Sule, Randall Mauldin, Adnan Zunic, Lori Karpes
  • Anti-CD40 Antibody Formulations
    Publication number: 20180264112
    Abstract: Provided herein, in some aspects, are low viscosity, low aggregation propensity, high anti-CD40 antibody concentration formulations.
    Type: Application
    Filed: January 15, 2016
    Publication date: September 20, 2018
    Inventors: Mark Krebs, Adnan Zunic, Tia Estey, Shantanu Sule, Margaret McGrath, Lori Karpes, Yana Kravets